CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753056237
- Phone
- 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- 4 Grant or award Chief Technology Officer acquired 12,428 shares (grant or award)
- 4 Grant or award CFO & Interim President acquired 9,824 shares (grant or award)
- 4 Grant or award CMO acquired 13,112 shares (grant or award)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Grant or award Chief Technology Officer acquired 13,020 shares (grant or award)
- 4 Grant or award CFO & Interim President acquired 10,292 shares (grant or award)
- 4 Grant or award CMO acquired 13,736 shares (grant or award)
- 8-K Event Unregistered share sale · Executive or director change
- 4 Grant or award Chief Technology Officer acquired 13,671 shares (grant or award)
- 4 Grant or award CFO & Interim President acquired 10,807 shares (grant or award)
- 4 Grant or award CMO acquired 14,423 shares (grant or award)
- 4 Grant or award CMO acquired 89,985 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 85,296 shares (grant or award)
- 4 Grant or award See Remarks acquired 30,696 shares (grant or award)
- 4 Grant or award CFO & Interim President acquired 67,425 shares (grant or award)
- 8-K Event Unregistered share sale
- 8-K Event Material agreement · Unregistered share sale · Executive or director change
- 8-K Event Unregistered share sale
- 8-K Event Unregistered share sale
- 8-K Event Executive or director change
Page 14 of 71 · 1,401 filings